A team from University Hospitals Seidman Cancer Center is launching the nation’s first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, Lipofen) as an investigational and potential treatment for patients with HPV+ cervical and HPV+ head and neck cancer (HNSCC).
Kentucky’s $42m Ibogaine Funding Appears Dead in the Water – Psychedelic Alpha
The seed was planted when Hubbard stumbled upon a Substack column by Julia Christina in 2021. The newsletter, called The Journey, has just over a
December 29, 2023